These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 16429272)

  • 1. Safety of iobitridol in the general population and at-risk patients.
    Vogl TJ; Honold E; Wolf M; Mohajeri H; Hammerstingl R
    Eur Radiol; 2006 Jun; 16(6):1288-97. PubMed ID: 16429272
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Safety and tolerability of iobitridol in general and in patients with risk factors: results in more than 160,000 patients.
    Maurer M; Heine O; Wolf M; Freyhardt P; Schnapauff D; Hamm B
    Eur J Radiol; 2011 Nov; 80(2):357-62. PubMed ID: 20395094
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intravenous contrast media in uroradiology: evaluation of safety and tolerability in almost 50,000 patients.
    Wendt-Nordahl G; Rotert H; Trojan L; Michel MS; Peters CR; Alken P; Knoll T
    Med Princ Pract; 2006; 15(5):358-61. PubMed ID: 16888393
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Safety Analysis of Iobitridol as a Nonionic Contrast Medium: A Postmarketing Multicenter Surveillance Study With 94,960 Patients Almost 20 Years After Introduction.
    Gorodetski B; Heine O; Wolf M; Collettini F; Hamm B; Darmon-Kern E; Penzkofer T
    Invest Radiol; 2020 Mar; 55(3):144-152. PubMed ID: 31977601
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence of acute reactions to iopromide: postmarketing surveillance study of 74,717 patients.
    Kopp AF; Mortele KJ; Cho YD; Palkowitsch P; Bettmann MA; Claussen CD
    Acta Radiol; 2008 Oct; 49(8):902-11. PubMed ID: 18651252
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Results of the safety and efficacy of iobitridol in more than 61,000 patients.
    Petersein J; Peters CR; Wolf M; Hamm B
    Eur Radiol; 2003 Aug; 13(8):2006-11. PubMed ID: 12942302
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical tolerance and diagnostic efficacy of iobitridol in contrast-enhanced CT in children.
    Smets A; Shaw D
    Acta Radiol Suppl; 1996; 400():65-7. PubMed ID: 8619355
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safety and tolerability of iopromide in patients undergoing cardiac catheterization: real-world multicenter experience with 17,513 patients from the TRUST trial.
    Chen JY; Liu Y; Zhou YL; Tan N; Zhang B; Chen PY; Chen LB
    Int J Cardiovasc Imaging; 2015 Oct; 31(7):1281-91. PubMed ID: 26058857
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Less iodine injected for the same diagnostic performances: comparison of two low-osmolar contrast agents (iobitridol 350 and iopamidol 370) in coronary angiography and ventriculography: a randomized double-blind clinical study.
    Velázquez MT; Albarrán A; Hernández F; García Tejada J; Zueco J; Andreu J; De la Torre JM; Figueroa A; Sainz F; Tascón J
    Acta Cardiol; 2010 Aug; 65(4):387-94. PubMed ID: 20821930
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and safety of iobitridol versus iohexol for contrast-enhanced CT of the head.
    Drouillard J; Froment JC; Frija G; Caille JM; Gandon Y; Clarisse J; Gaston A
    Acta Radiol Suppl; 1996; 400():56-61. PubMed ID: 8619353
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safety and efficacy of the new iodinated nonionic low-osmolality contrast medium Iobitridol (Xenetix) in coronary and ventricular angiography.
    Lefevre T; Funck F; Aliot E; Ethevenot B
    Acta Radiol Suppl; 1996; 400():75-80. PubMed ID: 8619358
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety and tolerability of iobitridol in cerebral angiography: a prospective, multicenter study.
    Heo YJ; Jeong HW; Kim D; Baek JW; Lee TH; Hwangbo L; Shin SH
    Acta Radiol; 2020 Mar; 61(3):331-337. PubMed ID: 31319690
    [No Abstract]   [Full Text] [Related]  

  • 13. Post-marketing surveillance of the safety profile of iodixanol in the outpatient CT setting: a prospective, multicenter, observational study of patient risk factors, adverse reactions and preventive measures in 9953 patients.
    Müller FH
    Rofo; 2014 Nov; 186(11):1028-34. PubMed ID: 24729407
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of a new monomeric nonionic radiographic contrast medium (iobitridol-350 versus NaCl) on cutaneous microcirculation: single-center, prospective, randomized, double-blind phase IV study in parallel group design.
    Bach R; Gerk U; Mrowietz C; Jung F
    Microvasc Res; 2000 Nov; 60(3):193-200. PubMed ID: 11078635
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Baseline characteristics, diagnostic efficacy, and peri-examinational safety of IV gadoteric acid MRI in 148,489 patients.
    Braun J; Busse R; Darmon-Kern E; Heine O; Auer J; Meyl T; Maurer M; Hamm B; de Bucourt M
    Acta Radiol; 2020 Jul; 61(7):910-920. PubMed ID: 31739672
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical tolerance and diagnostic efficacy of iobitridol 300 in lower limb angiography.
    Stockx L; Wilms G; Baert AL; Terrier F
    Acta Radiol Suppl; 1996; 400():72-4. PubMed ID: 8619357
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A prospective, randomized trial to determine the early and late reactions after the use of iopamidol 340 (Niopam) and iobitridol 350 (Xenetix) in cardiac catheterization.
    Vijayalakshmi K; Williams D; Wright RA; Hall JA; Harcombe AA; Linker NJ; Stewart MJ; Davies A; de Belder MA
    J Invasive Cardiol; 2004 Dec; 16(12):707-11. PubMed ID: 15596875
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Re-exposure to low osmolar iodinated contrast media in patients with prior moderate-to-severe hypersensitivity reactions: A multicentre retrospective cohort study.
    Park HJ; Park JW; Yang MS; Kim MY; Kim SH; Jang GC; Nam YH; Kim GW; Kim S; Park HK; Jung JW; Park JS; Kang HR
    Eur Radiol; 2017 Jul; 27(7):2886-2893. PubMed ID: 27975150
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A comparison of the efficacy and safety of ioxaglate and iobitridol in renal angioplasty.
    Dieu V; Joffre F; Krause D; Bartoli JM; Lyonnet D; Veyret C; Garcier JM; Boyer L
    Cardiovasc Intervent Radiol; 2000; 23(2):91-6. PubMed ID: 10795832
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Iobitridol 300 compared to iopromide 300--a double-blind randomized phase-III study of clinical tolerance in total body CT.
    Hoogewoud HM; Woessmer B
    Acta Radiol Suppl; 1996; 400():62-4. PubMed ID: 8619354
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.